Pacer BioThreat Strategy ETF (VIRS): Price and Financial Metrics ETF

Pacer BioThreat Strategy ETF (VIRS): $33.96

0.35 (+1.04%)

POWR Rating

Component Grades

Buy & Hold

A

Peer

D

Add VIRS to Watchlist
Sign Up

Category: Large Cap Blend ETFs

Category

C

Ranked

#209 of 280

in category

VIRS Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market

Current price $33.96 52-week high $36.26
Prev. close $33.61 52-week low $27.78
Day low $33.96 Volume 100
Day high $33.96 Avg. volume 190
50-day MA $35.19 Dividend yield 0.97%
200-day MA $32.12

VIRS Stock Price Chart Interactive Chart >


Pacer BioThreat Strategy ETF (VIRS) ETF Bio


The investment seeks to track the performance, before fees and expenses, of the LifeSci BioThreat Strategy Index (the index). Under normal circumstances, at least 80% of the funds total assets (exclusive of collateral held from securities lending) will be invested in the component securities of the index. The index is generally composed of U.S.-listed stocks of companies whose products or services help protect against, endure, or recover from biological threats to human health. It is non-diversified.

VIRS ETF Info

Issuer Pacer Financial
Expense Ratio 0.7%
Underlying Index LifeSci BioThreat Strategy Index
Asset Class Equity
Sector Large Cap Blend ETFs
Assets Under Management (AUM) 3.40M
Net Asset Value (NAV) $33.96
Options? Yes
Total Holdings 56

VIRS Top Holdings

Symbol Company % of Total
NVDA NVIDIA Corp 7.88%
NFLX Netflix Inc 5.94%
AMZN Amazon.com Inc 5.37%
MRK Merck & Co Inc 5.33%
WMT Walmart Inc 5.21%
TMO Thermo Fisher Scientific Inc 4.88%
DHR Danaher Corp 4.8%
LOW Lowe s Cos Inc 4.67%
HD Home Depot Inc/The 4.5%
ABT Abbott Laboratories 4.45%

VIRS Price Returns

1-mo -6.26%
3-mo 3.69%
6-mo 19.97%
1-year 15.38%
3-year 14.77%
5-year N/A
YTD 5.31%
2023 15.67%
2022 -18.02%
2021 25.50%
2020 N/A
2019 N/A

VIRS Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full VIRS Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!